A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer

Authors

Rahul Krishnatry (ORCID: https://orcid.org/0000-0003-4511-7782)
Prachi Patil (ORCID: https://orcid.org/0000-0002-5809-6282)
Sanjeev Galande (ORCID: https://orcid.org/0000-0002-7251-1905)
Priya Ranganathan (ORCID: https://orcid.org/0000-0003-1004-5264)
Ekta Gupta
Avanish Saklani (ORCID: https://orcid.org/0000-0003-4498-7612)
Anant Ramaswamy (ORCID: https://orcid.org/0000-0002-8169-4264)
Reena Engineer (ORCID: https://orcid.org/0000-0002-3893-1287)
Vikas S Ostwal (ORCID: https://orcid.org/0000-0002-0067-4748)
Naveena A. N. Kumar (ORCID: https://orcid.org/0000-0002-1759-1500)
Munita Bal (ORCID: https://orcid.org/0000-0002-0345-5620)
Mufaddal Khuzema Kazi (ORCID: https://orcid.org/0000-0002-3295-0006)
Ashwin Desouza
Snehal Khanvilkar

Institutions

Manipal Academy of Higher Education (IN)
Indian Institute of Science Education and Research Pune (IN)
Homi Bhabha National Institute (IN)
Tata Memorial Hospital (IN)
Kasturba Medical College, Manipal (IN)

Publication Details

Journal: Frontiers in Oncology
Published: 2025-03-19
DOI: https://doi.org/10.3389/fonc.2025.1450602
Citations: 3
Primary Topic: Cancer, Lipids, and Metabolism
Type: article
Field-Weighted Citation Impact: 2.81

Funders

Department of Biotechnology, Ministry of Science and Technology, India
Tata Memorial Centre

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer

Rahul Krishnatry, Prachi Patil, Sanjeev Galande, Priya Ranganathan et al.

Mar 19, 2025

3 citations

Frontiers in Oncology

Cancer, Lipids, and Metabolism

2.81

article

A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer

Rahul Krishnatry, Prachi Patil, Sanjeev Galande, Priya Ranganathan, Ekta Gupta, Avanish Saklani, Anant Ramaswamy, Reena Engineer, Vikas S Ostwal, Naveena A. N. Kumar, Munita Bal, Mufaddal Khuzema Kazi, Ashwin Desouza, Snehal Khanvilkar

March 19, 2025article en

3 citations

Abstract

No abstract available for this paper.

Frontiers in OncologyVol. 15

Manipal Academy of Higher Education (IN), Indian Institute of Science Education and Research Pune (IN), Homi Bhabha National Institute (IN), Tata Memorial Hospital (IN), Kasturba Medical College, Manipal (IN)

Department of Biotechnology, Ministry of Science and Technology, India, Tata Memorial Centre

Good health and well-being

Openalex Percentile: Top 11%

Cancer, Lipids, and Metabolism

2.81

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer — Rahul Krishnatry, Prachi Patil, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS